Immunotherapy for Renal Cell Carcinoma

This publication has 73 references indexed in Scilit:

• Cancer immunoediting: from immunosurveillance to tumor escape
  Nature Immunology, 2002
• Interleukin 2 Gene Therapy for Prostate Cancer: Phase I Clinical Trial and Basic Biology
  Human Gene Therapy, 2001
• Ig-binding Receptors on Human NK Cells as Effector and Regulatory Surface Molecules
  International Reviews of Immunology, 2001
• Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention
  BJU International, 2000
• A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.
  The Journal of Experimental Medicine, 1996
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• A dual anti-tumor effect of a combination of interferon-α or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity
  Clinical Immunology and Immunopathology, 1992
• Autologous Tumor-Specific Cytotoxicity of Tumor-Infiltrating Lymphocytes Derived from Human Renal Cell Carcinoma
  Journal of Immunotherapy, 1991
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991
• Internalization and degradation of macrophage Fc receptors during receptor-mediated phagocytosis.
  The Journal of cell biology, 1983